Sarepta Therapeutics Inc Stock Guidance

SRPTNASDAQ
$15.78
0.010.06%
At close: Jun 16, 5:00 PM EST
$15.73
-0.05-0.32%
After Hours: 7:59 PM EST

Sarepta Therapeutics (SRPT) last issued guidance on August 2, 2022 for fiscal year 2022. The company guided revenue in the range of $905.00M - $920.00M for the period.

Latest Guidance Date
Aug 2, 2022
Guidance Period
Full Year 2022
Revenue Guidance Range
$905.00M - $920.00M

Sarepta Therapeutics Guidance History

Review all historical guidance issued by Sarepta Therapeutics, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

Q

What is the most recent guidance for Sarepta Therapeutics (SRPT)?

A

The most recent guidance for Sarepta Therapeutics (SRPT) was reported on August 2, 2022 for the fiscal year 2022. Sarepta Therapeutics forecasted revenue between $905.00M and $920.00M for the period.

Q

What revenue range did Sarepta Therapeutics (SRPT) guide for?

A

Sarepta Therapeutics (SRPT) guided revenue in the range of $905.00M to $920.00M for the fiscal year 2022.

Q

When did Sarepta Therapeutics (SRPT) last issue guidance?

A

Sarepta Therapeutics (SRPT) last issued guidance on August 2, 2022 for the fiscal year 2022.